Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.

MLA

Yamasaki, Kai, et al. “Strategy to Minimize Radiation Burden in Infants and High-Risk Medulloblastoma Using Intrathecal Methotrexate and High-Dose Chemotherapy: A Prospective Registry Study in Japan.” Pediatric Blood & Cancer, vol. 67, no. 1, Jan. 2020, p. e28012. EBSCOhost, https://doi.org/10.1002/pbc.28012.

APA

Yamasaki, K., Okada, K., Soejima, T., Sakamoto, H., & Hara, J. (2020). Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan. Pediatric Blood & Cancer, 67(1), e28012. https://doi.org/10.1002/pbc.28012

Chicago

Yamasaki, Kai, Keiko Okada, Toshinori Soejima, Hiroaki Sakamoto, and Junichi Hara. 2020. “Strategy to Minimize Radiation Burden in Infants and High-Risk Medulloblastoma Using Intrathecal Methotrexate and High-Dose Chemotherapy: A Prospective Registry Study in Japan.” Pediatric Blood & Cancer 67 (1): e28012. doi:10.1002/pbc.28012.